PFC
LFCR icon

Poplar Forest Capital’s Lifecore Biomedical LFCR Stock Holding History

Poplar Forest Capital’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,520
Closed -$208K – 86
2021
Q2 		$208K Sell
18,520
-12,839
-41% -$148K 0.02% 84
2021
Q1 		$332K Hold
31,359
– – 0.03% 65
2020
Q4 		$340K Buy
31,359
+5,661
+22% +$58.5K 0.04% 53
2020
Q3 		$250K Buy
25,698
+11,614
+82% +$111K 0.03% 54
2020
Q2 		$112K Buy
14,084
+3,168
+29% +$32.7K 0.01% 58
2020
Q1 		$95K Buy
+10,916
New +$114K 0.01% 61

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Poplar Forest Capital's LFCR Position: Q3 2021 in Review

Poplar Forest Capital sold out of Lifecore Biomedical (LFCR) in Q3 2021, closing a stake of 18,520 shares — an estimated $208K sold.

Poplar Forest Capital first reported a position in LFCR in Q1 2020 and held it in 6 quarters. The position peaked at $340K in Q4 2020. 92 funds tracked by Wall St. Rank hold LFCR as of Q3 2021.

  • Poplar Forest Capital reported no remaining Lifecore Biomedical position as of Q3 2021 after selling out during the quarter.
  • Poplar Forest Capital sold 18,520 Lifecore Biomedical shares in Q3 2021, an estimated $208K.
  • Poplar Forest Capital first reported a position in Lifecore Biomedical in Q1 2020 and held it in 6 quarters.
  • Poplar Forest Capital's Lifecore Biomedical position peaked at $340K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2021.

Based on Poplar Forest Capital's 13F filing for Q3 2021, filed 9 Nov 2021.